NorthWest Biotherapeutics Inc (NWBO)

[Dan88]

Nonsense

Fox and AVII and you are incorrect to say that the DCVax-L trial results are not the results of a randomized placebo controlled trial.

The trial results are obtained from a randomized placebo controlled trial, which will compare OS and PFS of treatment arm with the placebo arm within the trial as secondary endpoints.

The fact that its primary OS endpoint results are compared with those of comparable trail placebo arms of other similar trials doesn't change the fact the DCVax-L trial is a randomized placebo controlled trial.

As the publication of DCVax-L trial in either NEJM or Lancet, you are even far off. The merit of publication in high profile journals is always focused on POTENTIAL IMPACT, and quality of the data.

No results of any trials in the realm of GMB treatment will have more positive impacts than those of DCVax-L trial to be revealed if the results repeats or better than what we have known from the blinded blended publication and its subsequent update.

Open your mind a better open, and don't miss the opportunity!

Need to run with friends for some fun this afternoon. To many soft FUDs recently from amateurs, "Full Professors." Must have been not enough of cheap shares. I bet we will see a publication of DCVax-L trial results in either NEJM or Lancet soon. Do you want to bet?